fda shortage tirzepatide update off the list What Is Tirzepatide Used for? Approved and Potential Uses FDA says tirzepatide shortage is

Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes are a type of medication used to treat type 2 diabetes. They contain the active ingredient tirzepatide, which belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. This medication is delivered as a pre-filled syringe that contains 7.5 mg of tirzepatide in a solution of 0.5 mL. It is given as a subcutaneous injection (under the skin) once a week and works by mimicking the function of a naturally occurring hormone in the body called GLP-1, which helps regulate blood sugar levels. Mounjaro is intended to be used in conjunction with a healthy diet and exercise to help control blood sugar in adults with type 2 diabetes. It may also help in weight management for people with obesity or overweight. As with any medication, it is important to follow the instructions of a healthcare professional and to report any side effects experienced

Now, a US-wide trial will test whether tirzepatide, the active ingredient in Zepbound, may be an effective treatment for people with long Covid

This superimposed insulin resistance leads to an increased insulin response, affecting placental development

Dopamine and the reward system Tirzepatide also affects dopaminergic pathways